Investors are delving into the details on shares of Cymabay Therapeutics (CBAY). The equity price has climbed the ladder moving past the Stochtastic Momentum Index of +40, indicating possible overbought territory.
The Stochastic Momentum Index, or SMI, is a more refined version of the original stochastic oscillator, employing a wider range of values and having a higher sensitivity to closing prices. The Stochastic Momentum Index (SMI) indicator was developed by William Blau and is based on the Stochastic indicator. The Stochastic oscillator is determined using the close price relative to the high low trading range, whereas the Stochastic Momentum Index indicator is determined using the close price relative to the midpoint of the high low trading range. The most common method of using SMI is to look for buy trades when the SMI falls under -40 and then rises back above through -40. Sell trades are looked for when the SMI rises above +40 and then falls back below +40.
Investors may be trying to get a read on the next big equity market move. Projecting which stocks are ready to make a run can be tricky. Many investors will track the market from various angles in order to make the best educated decisions. Keeping tabs on all the imperative economic indicators can assist when analyzing the overall health of the equity market. Some financial strategists may be projecting a farsighted downturn over the next few months while others believe that there is no tangible reason for the market to lose the near-term momentum.
Traders are taking a closer look at shares of Cymabay Therapeutics (CBAY) of late. The 14-day RSI is currently at 40.32, the 7-day is at 39.15, and the 3-day is resting at 42.75. The Relative Strength Index (RSI) is one of various crowd-pleasing technical indicators developed by J. Welles Wilder. Wilder introduced RSI in his publication “New Concepts in Technical Trading Systems” which was released in 1978. RSI measures the magnitude and velocity of directional price movements. The data is represented graphically by fluctuating between a value of 0 and 100. The indicator is computed by using the average losses and gains of a stock over a certain time timeframe. RSI can be used to assist bring to light overbought or oversold conditions. An RSI reading over 70 would be considered overbought, and a reading under 30 would indicate oversold conditions. A level of 50 would indicate neutral market momentum.
In terms of CCI levels, Cymabay Therapeutics (CBAY) right now has a 14-day Commodity Channel Index (CCI) of -52.56. Investors and traders may use this indicator to assist bring to light price reversals, price extremes, and the strength of a trend. Many investors will use the CCI in conjunction with nonstandard indicators when evaluating a trade. The CCI may be used to bring to light if a stock is entering overbought (+100) and oversold (-100) territory. The 14-day ADX is 26.19. Many technical chart analysts believe that an ADX reading over 25 would suggest a strong trend. A level under 20 would indicate no trend, and a reading from 20-25 would suggest that there is no clear trend signal. The ADX is typically plotted along with two nonstandard directional movement indicator lines, the Plus Directional Indicator (+DI) and Minus Directional Indicator (-DI). Some analysts believe that the ADX is one of the best trend strength indicators available.
Investors may be considering nonstandard technical indicators like the Williams Percent Range or Williams %R. The Williams %R is a momentum indicator that helps add up oversold and overbought levels. This indicator compares the closing price of a stock in relation to the highs and lows over a certain time timeframe. A common look back timeframe is 14 days. Cymabay Therapeutics (CBAY)’s Williams %R currently stands at -64.38. The Williams %R oscillates in a range from 0 to -100. A reading between 0 and -20 would indicate an overbought situation. A reading from -80 to -100 would indicate an oversold situation. Looking at some moving average levels, the 200-day is at 12.26, the 50-day is 10.57, and the 7-day is sitting at 9.12. Moving averages can assist identify trends and price reversals. They may also be used to assist bring to light support and resistance levels. Moving averages are considered to be lagging indicators meaning that they confirm trends. A certain stock may be considered to be on an uptrend if trading above a moving average and the average is sloping upward. On the nonstandard side, a stock may be considered to be in a downtrend if trading below the moving average and sloping downward.
As the next firm earnings course comes into focus, investors may be closely following the numbers as they are released. Some investors will select to remain away from any big trades during earnings course. Others will opt to try to capitalize on equity price fluctuations that may occur before and after the earnings report. Wall Street analysts may be getting ready to make estimate revisions over the next couple of weeks. Investors have the ability to keep track of broker estimates and recommendations when undertaking stock analysis. Investors may select to review broker projections and then make their own decisions on what they think the firm will report for the quarter.
